METHODS: Developed acoustic-solution-sonication-casting methods were applied to fabricate the new graphene-polymer-dental filler nanocomposites. The structure, morphology, rheological and mechanical properties, and antibacterial of the newly fabricated filling-PMMA/ GO nanocomposites were investigated.
RESULTS: Fourier transform infrared (FTIR) showed a significant interaction between the filling and the additional materials. The X-ray diffraction (XRD) analysis revealed a considerable change in crystalline behavior. Optical microscope (OM) with field emission scanning electron microscopy (FESEM) pictures demonstrated a substantial change in the morphology of the samples with a homogeneous and fine dispersion of the nanomaterials in the filler matrix. Multi-frequency ultrasound mechanical properties measured the ultrasonic velocity, absorption coefficient, compressibility, bulk modulus, and other mechanical properties that notably enhanced after GO contributed up to 325% of the ultrasonic absorption coefficient compared with hybrid/nano-fillers. Rheological properties were measured as viscosity, absorption coefficient, and specific viscosity, which significantly improved after adding PMMA and incorporating GO up to 57% of the viscosity, compared with hybrid/nano-fillers. The inhibition zone of moth bacteria, such as Enterococcus faecalis and E. staph bacteria, improved after the contribution of GO nanosheets up to 46%.
CONCLUSION: Nanofillers nanocomposites presented better properties and inhabitances zone diameter of antibacterial.
METHODS: The study encompassed a comprehensive three-stage approach to the development and validation of the PROM. Initially, during the preliminary design stage, the necessity for a new PROM was recognized, an expert panel was formed, and semi-structured qualitative interviews were carried out with GSM patients. In the second stage, the study used the five-step pre-validation methodology established by Prior et al. to generate and refine the PROM items. The third and final stage encompassed the determination of scale and item content validity indexes to ensure validity. Additionally, the reliability of each construct was evaluated using Cronbach's α.
RESULTS: The resulting PROM was named GSM-SVTAQ (GSM-symptoms and vaginal treatments acceptability questionnaire). It demonstrated excellent validity in assessing symptoms burden, health-related and sexual quality of life, and vaginal treatment acceptability, with high content validity indices and strong internal consistency. The scale content validity indices and Cronbach's α coefficients for the three domains were (0.926, 0.939), (0.875, 0.947), and (0.824, 0.855), respectively.
CONCLUSION: The GSM-SVTAQ stands as the first GSM-specific, valid, and reliable PROM capable of comprehensively measuring the three components of GSM and the acceptability of vaginal treatments. Its implementation has the potential to significantly enhance patient care and outcomes in GSM management.